We observed that cotreatment with BRI, LAT, or OMD significantly downregulated the mRNA and protein levels of GRP78, which suggested the overall level of ER stress was reduced in tunicamycin-treated human TM cells. The gene discussed is HSPA5; the disease is occult macular dystrophy.